Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
MDL71782 hydrochloride
4-benzoxazepin-7-yl]pyridin-2-amine
to assess the anti-tumor activity of Salinomycin
InChi: InChI=1S/C15H11ClN2OS/c16-11-3-1-10(2-4-11)14-9-20-15(18-14)17-12-5-7-13(19)8-6-12/h1-9
2 μM and has no significant effect on both the inward rectifier potassium current and the L-type calcium current
Naratriptan Hydrochloride - CAS# 143388-64-1 Catalog No.:M10095-2 MDL71782 hydrochlorideNaratriptan is a selective 5 HT1 receptor subtype agonist for the treatment of migraine headache. Naratriptan binds with high affinity to human cloned 5 HT1B 1D receptors. Migraines are likely due to local cranial vasodilatation and or to the release of sensory neuropeptides (including substance P and calcitonin gene related peptide) through nerve endings in the trigeminal system. The therapeutic activity of AMERGE for the treatment of migraine
US$ 16.00
US$ 1817.00
US$ 132.50
US$ 15.60
US$ 195.00